We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKSH icon
6826
National Bankshares
NKSH
$259M
$10K ﹤0.01%
226
-347
-61% -$13.8K
NTIP icon
6827
Network-1 Technologies
NTIP
$37M
$10K ﹤0.01%
2,728
-2,675
-50% -$10.6K
OESX icon
6828
Orion Energy Systems
OESX
$41M
$10K ﹤0.01%
866
+420
+94% +$4.49K
OMEX icon
6829
Odyssey Marine Exploration
OMEX
$34.9M
$10K ﹤0.01%
2,341
+672
+40% +$2.81K
PRTS icon
6830
CarParts.com
PRTS
$43.7M
$10K ﹤0.01%
+333
New +$9.54K
PSCU icon
6831
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$17.3M
$10K ﹤0.01%
180
-2,382
-93% -$126K
SYRE icon
6832
Spyre Therapeutics
SYRE
$8.54B
$10K ﹤0.01%
78
-26
-25% -$2.44K
TAP.A icon
6833
Molson Coors Class A
TAP.A
$10K ﹤0.01%
125
TMV icon
6834
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$187M
$10K ﹤0.01%
200
-40
-17% -$1.9K
TNXP icon
6835
Tonix Pharmaceuticals
TNXP
$160M
0
WILC icon
6836
G. Willi-Food International
WILC
$373M
$10K ﹤0.01%
+1,748
New +$11.5K
GTHX
6837
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$10K ﹤0.01%
400
-495
-55% -$9.14K
LSXMB
6838
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$10K ﹤0.01%
324
-488
-60% -$15.7K
GENE
6839
DELISTED
Genetic Technologies Ltd.
GENE
$10K ﹤0.01%
583
+19
+3% +$317
CYAN
6840
DELISTED
Cyanotech Corp
CYAN
$10K ﹤0.01%
+2,478
New +$10.1K
JPT
6841
DELISTED
Nuveen Preferred and Income Fund
JPT
$10K ﹤0.01%
+400
New +$10.1K
AHPI
6842
DELISTED
Allied Healthcare Products
AHPI
$10K ﹤0.01%
+4,543
New +$10.1K
EMBH
6843
DELISTED
iShares Interest Rate Hedged Emerging Markets Bond ETF
EMBH
$10K ﹤0.01%
380
-58
-13% -$1.51K
ESBK
6844
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$10K ﹤0.01%
+541
New +$10.4K
DISCB
6845
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$10K ﹤0.01%
431
+71
+20% +$1.77K
MMAC
6846
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$10K ﹤0.01%
380
SMTX
6847
DELISTED
SMTC Corporation
SMTX
$10K ﹤0.01%
+8,022
New +$10.2K
CHEP
6848
DELISTED
AGFiQ U.S. Market Neutral Value Fund
CHEP
$10K ﹤0.01%
+400
New +$10.2K
NBRV
6849
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10K ﹤0.01%
+5
New +$11.7K
YGYI
6850
DELISTED
Youngevity International, Inc Common Stock
YGYI
$10K ﹤0.01%
+2,059
New +$10.4K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.